Horizon Therapeutics Plc (HZNP)

27.27
NASDAQ : Health Technology
Prev Close 26.50
Day Low/High 26.46 / 27.44
52 Wk Low/High 16.56 / 29.44
Avg Volume 1.80M
Exchange NASDAQ
Shares Outstanding 186.45M
Market Cap 4.94B
EPS -0.50
P/E Ratio 68.38
Div & Yield N.A. (N.A)
Horizon Shares Rise on Q3 Results, Guidance -- Biotech Movers

Horizon Shares Rise on Q3 Results, Guidance -- Biotech Movers

The Dublin firm on Nov. 6 unveiled third-quarter numbers that topped analysts' estimates and raised its full-year net sales outlook and the lower end of its 2017 adjusted Ebitda guidance.

Roku, Nucana and Other IPOs That Should Be on Your Radar in 2017

Roku, Nucana and Other IPOs That Should Be on Your Radar in 2017

Newly public companies such as Roku, NuCana and Restoration Robotics could bring a jolt to your portfolio. But remember all IPOs aren't created equally.

Dow Scores Ninth Straight Record Close With Tiny Gains, S&P 500 at All-Time High

Dow Scores Ninth Straight Record Close With Tiny Gains, S&P 500 at All-Time High

DJIA, S&P 500 and Nasdaq all rise slightly on the session.

Dow Is Back on Track to Close at a Record High as Consumer Staples Lead

Dow Is Back on Track to Close at a Record High as Consumer Staples Lead

The Dow has closed with a record for eight straight days. It's going for its ninth.

Energy Losses Put Dow's Record-Breaking Streak in Jeopardy

Energy Losses Put Dow's Record-Breaking Streak in Jeopardy

The Dow could close with its ninth day of records.

Biotech Movers: Second Quarter Results, Increased Outlook Send Horizon Pharma Shares Higher

Biotech Movers: Second Quarter Results, Increased Outlook Send Horizon Pharma Shares Higher

Horizon Pharma, Mylan and Intellia Therapeutics were among the biotech stock movers in premarket trading on Aug. 7.

Stock Futures Rise as Dow Shoots for Its Ninth Straight Day of Records

Stock Futures Rise as Dow Shoots for Its Ninth Straight Day of Records

Stock futures are higher.

Horizon Pharma Stock Sees Short Interest Expand By 18.7%

Horizon Pharma Stock Sees Short Interest Expand By 18.7%

The most recent short interest data has been released for the 07/14/2017 settlement date, which shows a 2,838,341 share increase in total short interest for Horizon Pharma plc , to 17,983,730, an increase of 18.74% since 06/30/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Horizon Pharma Plc Announces Four Poster Presentations On PROCYSBI® (Cysteamine Bitartrate) Delayed-Release Capsules At Cystinosis Research Network 2017 Family Conference

Horizon Pharma Plc Announces Four Poster Presentations On PROCYSBI® (Cysteamine Bitartrate) Delayed-Release Capsules At Cystinosis Research Network 2017 Family Conference

-- In a New Study Comparing PROCYSBI and Immediate-Release Cysteamine, Those Treated with PROCYSBI Had a 26 Percent Reduction in Exhaled Dimethyl Sulphide, Which is Associated with Halitosis --

TheStreet Quant Rating: C+ (Hold)